To visit the old Ventura website, click here.
Ventura Wealth Clients
2 min Read

Biocon shares rise 5% after USFDA VAI approval

Biocon’s shares surged by 5% in early trade on November 11 following a significant regulatory update. The USFDA or Food and Drug Administration, granted Biocon's...

By Ventura Research Team